Recently, circulation markers, e.g., glycoproteins CEA (carcinoembryonic antigen) and CA19-9 (cancer antigen 19-9) are widely used for CRC diagnosis [124,125,126] but miRNAs in the circulation are also promising markers for CRC diagnosis. This evidence concerns the gene CEACAM5 and colorectal carcinoma.